Cegedim and SDI launch oncology audit
The new Oncology Selling Audit will launch in January and contain data from a sample of medical and radiation oncologists and haematologists.
The monthly service will provide nationally projected measures of personal selling in the oncology market, including competitive corporate calls, messages and promotional spending. Sectors covered include tumour type, staging and modalities.
Cegedim’s COO for sales and marketing Bruno Lempernesse said: “We are pleased to be partnering with SDI to bring this key service to the marketplace. This launch reaffirms the commitment to innovation that both organisations bring to healthcare measurement. This partnership will benefit from CSD’s global experience in promotion audits and allow for more in-depth analysis of sales and marketing strategies for all cancer treatments.”

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments